Sensei Biotherapeutics, Inc. (SNSE)
NASDAQ: SNSE · Real-Time Price · USD
0.3628
+0.0028 (0.78%)
At close: May 12, 2025, 4:00 PM
0.3501
-0.0127 (-3.50%)
After-hours: May 12, 2025, 6:55 PM EDT

Sensei Biotherapeutics Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2015 - 2019
Period Ending
Mar '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
Selling, General & Admin
12.0712.3418.7719.8115.827.53
Upgrade
Research & Development
17.4418.6318.330.3821.6611.19
Upgrade
Operating Expenses
29.5130.9637.0650.1937.4818.71
Upgrade
Operating Income
-29.51-30.96-37.06-50.19-37.48-18.71
Upgrade
Interest Expense
-0.08-0.09-0.14-0.22-0.67-1.69
Upgrade
Interest & Investment Income
2.192.553.621.780.8-
Upgrade
Other Non Operating Income (Expenses)
-0.97-0.99-1.270.250.611
Upgrade
EBT Excluding Unusual Items
-28.36-29.49-34.86-48.37-36.75-19.41
Upgrade
Merger & Restructuring Charges
-0.7-0.7----
Upgrade
Gain (Loss) on Sale of Investments
0.990.991.06-0.22-0.62-
Upgrade
Gain (Loss) on Sale of Assets
---0.3---
Upgrade
Asset Writedown
-0.95-0.95----
Upgrade
Other Unusual Items
----0.570.05
Upgrade
Pretax Income
-29.03-30.16-34.1-48.59-36.79-20.1
Upgrade
Earnings From Continuing Operations
--30.16-34.1-48.59-36.79-20.1
Upgrade
Net Income
-29.03-30.16-34.1-48.59-36.79-20.1
Upgrade
Preferred Dividends & Other Adjustments
-----0.1
Upgrade
Net Income to Common
-29.03-30.16-34.1-48.59-36.79-20.2
Upgrade
Shares Outstanding (Basic)
25252831282
Upgrade
Shares Outstanding (Diluted)
25252831282
Upgrade
Shares Change (YoY)
-5.08%-10.14%-8.96%10.80%1618.88%338.85%
Upgrade
EPS (Basic)
-1.15-1.20-1.22-1.58-1.33-12.53
Upgrade
EPS (Diluted)
-1.15-1.20-1.22-1.58-1.33-12.53
Upgrade
Free Cash Flow
-24.26-24.82-32.2-39.35-32.29-18.91
Upgrade
Free Cash Flow Per Share
-0.96-0.99-1.15-1.28-1.17-11.73
Upgrade
EBITDA
-28.48-29.64-35.71-48.84-36.8-18.5
Upgrade
D&A For EBITDA
1.031.321.351.350.690.21
Upgrade
EBIT
-29.51-30.96-37.06-50.19-37.48-18.71
Upgrade
Updated Mar 28, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q